scorecardresearch
Add as a preferred source on Google
Friday, November 14, 2025
TopicDrugmakers

Topic: drugmakers

Blockbuster semaglutide set to go off patent, Indian pharma sees a multi-billion-dollar opportunity

Pharma firms are pouncing on opportunity as patents on world’s second-bestselling drug, which goes by brand names Ozempic and Wegovy, are expiring in nearly 100 nations.

Indian drugmakers relieved but wary as US exempts pharma sector from new trade tariffs

Industry insiders say any rise in duties on Indian generics will squeeze profits for Indian companies, but will also make the drugs costlier for patients in US.

Govt relents, relaxes GMP adoption deadline for small, medium pharmas after RSS-backed body weighs in

The proposed extension for drugmakers in adopting Schedule M of Drugs and Cosmetics Act and Rules comes mainly at the behest of RSS-backed Laghu Udyog Bharti, it is learnt.

Indian pharma firms now liable to recall defective drugs as Modi govt notifies new norms

Under revised good manufacturing practices (GMP) norms, pharma companies will be required to assume onus for quality of drugs to ensure they do not place patients at risk.

Reporting faulty manufacture to annual audits: How govt wants drugmakers to improve quality

Nearly 80 percent of small and medium drug manufacturing units in India do not follow good manufacturing practices (GMP) requirements, according to government estimates.

Govt allows existing stock of 14 banned fixed-dose combination drugs to be sold after HC order

Delhi High Court accepted pharma companies’ argument that most banned drugs had been in use for over 30 years and said health ministry had not specified reasons behind ban issued in June.

Govt sets deadline for pharma MSMEs to adopt good manufacturing practices. ‘Follow or be penalised’

Health minister concedes implementation of Schedule M of Drugs and Cosmetics Act has been poor. Timeline for adherence to norms for good manufacturing practices began on 1 August.

Poor documentation, lack of process — Govt finds string of deficiencies among drugmakers after probe

The health ministry has stepped up scrutiny of drugmakers in recent months after some cough syrups made in the country were linked to the deaths of at least 95 children overseas.

Trump is investing millions to bring drug making back to US from India and China

A spike in demand for some drugs & supplies has increased concerns about shortages in the US as 80% of active ingredients come from India, China.

PM Modi warns pharma companies not to bribe doctors with women, foreign trips and gadgets

Modi met senior officials from top drug-makers like Zydus Cadila, Torrent & Wockhardt, and said their non-compliance is forcing govt to create a strict law.

On Camera

From Virat & Anushka selling sarias to dentist ads, Bihar walls tell a ‘rurbanisation’ story

Over generations, Bihar’s bane has been its utter lack of urbanisation. But now, even Bihar is urbanising. Or let’s say, rurbanising. Two decades under Nitish Kumar have created a new elite in its cities.

Wealth nears $99 trillion, still Asia’s rich don’t have succession plans

Much of this wealth is tied to founder-led businesses that employ millions and help anchor regional economies.

Turkey blocks transport of Apache choppers to India through its airspace, new route being worked out

Indian govt officials last month skipped Turkish National Day celebrations in Delhi, in a message to Ankara following its support for Islamabad, particularly during Operation Sindoor.

Bihar is where politics moves, and everything else stands still

Bihar is blessed with a land more fertile for revolutions than any in India. Why has it fallen so far behind then? Constant obsession with politics is at the root of its destruction.